Additionally, CHFR (checkpoint protein with FHA and RING finger domains), a tumor suppressor, not only recognizes PARylation signaling at DNA damage sites but also demonstrates that the silencing of CHFR sensitizes GC to PARPi therapy [105]. Here, CHFR is linked to neoplasm.